Lisa Zimmer
9PUBLICATIONS
96CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jul 27, 2025
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial.Jürgen C Becker, Anja H Gesierich, Ulrike Leiter
|Jun 03, 2025
Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma.Georg C Lodde, Jessica C Hassel, Imke von Wasielewski
|Nov 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma.Giuseppe Tarantino, Cora A Ricker, Annette Wang
|Jan 31, 2024
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series.Catriona Harvey, Kazi J Nahar, Janet McKeown
|Sep 20, 2023
Treatment management for <i>BRAF</i>-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG.Maximilian Haist, Henner Stege, Friederike Rogall
Pageof 2
Frequent Collaborators
5 joint publications
Bastian Schilling
5 joint publications
Dirk Schadendorf
4 joint publications
Elisabeth Livingstone
2 joint publications
Ralf Gutzmer
2 joint publications
Selma Ugurel
2 joint publications
Jessica C Hassel
2 joint publications
Michael Postow
2 joint publications
Paolo A Ascierto
1 joint publications
Yasuhiro Nakamura
1 joint publications
Jiro Uehara
